日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

慢性淋巴细胞白血病向里氏综合征转变的演变史

Erin M Parry # ,Ignaty Leshchiner # ,Romain Guièze # ,Connor Johnson ,Eugen Tausch ,Sameer A Parikh ,Camilla Lemvigh ,Julien Broséus ,Sébastien Hergalant ,Conor Messer ,Filippo Utro ,Chaya Levovitz ,Kahn Rhrissorrakrai ,Liang Li ,Daniel Rosebrock ,Shanye Yin ,Stephanie Deng ,Kara Slowik ,Raquel Jacobs ,Teddy Huang ,Shuqiang Li ,Geoff Fell ,Robert Redd ,Ziao Lin ,Binyamin A Knisbacher ,Dimitri Livitz ,Christof Schneider ,Neil Ruthen ,Liudmila Elagina ,Amaro Taylor-Weiner ,Bria Persaud ,Aina Martinez ,Stacey M Fernandes ,Noelia Purroy ,Annabelle J Anandappa ,Jialin Ma ,Julian Hess ,Laura Z Rassenti ,Thomas J Kipps ,Nitin Jain ,William Wierda ,Florence Cymbalista ,Pierre Feugier ,Neil E Kay ,Kenneth J Livak ,Brian P Danysh ,Chip Stewart ,Donna Neuberg ,Matthew S Davids ,Jennifer R Brown ,Laxmi Parida ,Stephan Stilgenbauer ,Gad Getz ,Catherine J Wu

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

来自基因组或转录组的肿瘤和免疫信号组合可预测黑色素瘤检查点抑制的结果

Samuel S Freeman, Moshe Sade-Feldman, Jaegil Kim, Chip Stewart, Anna L K Gonye, Arvind Ravi, Monica B Arniella, Irena Gushterova, Thomas J LaSalle, Emily M Blaum, Keren Yizhak, Dennie T Frederick, Tatyana Sharova, Ignaty Leshchiner, Liudmila Elagina, Oliver G Spiro, Dimitri Livitz, Daniel Rosebrock,

Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies

线粒体重编程是淋巴系统恶性肿瘤对 BCL-2 抑制产生抗性的基础

Romain Guièze, Vivian M Liu, Daniel Rosebrock, Alexis A Jourdain, María Hernández-Sánchez, Aina Martinez Zurita, Jing Sun, Elisa Ten Hacken, Kaitlyn Baranowski, Philip A Thompson, Jin-Mi Heo, Zachary Cartun, Ozan Aygün, J Bryan Iorgulescu, Wandi Zhang, Giulia Notarangelo, Dimitri Livitz, Shuqiang Li

Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma

广泛的染色体丢失和线粒体 DNA 变异是 Hürthle 细胞癌的遗传驱动因素

Raj K Gopal, Kirsten Kübler, Sarah E Calvo, Paz Polak, Dimitri Livitz, Daniel Rosebrock, Peter M Sadow, Braidie Campbell, Samuel E Donovan, Salma Amin, Benjamin J Gigliotti, Zenon Grabarek, Julian M Hess, Chip Stewart, Lior Z Braunstein, Peter F Arndt, Scott Mordecai, Angela R Shih, Frances Chaves, 

Resistance to checkpoint blockade therapy through inactivation of antigen presentation

通过灭活抗原呈递而产生对免疫检查点阻断疗法的耐药性

Moshe Sade-Feldman ,Yunxin J Jiao ,Jonathan H Chen ,Michael S Rooney ,Michal Barzily-Rokni ,Jean-Pierre Eliane ,Stacey L Bjorgaard ,Marc R Hammond ,Hans Vitzthum ,Shauna M Blackmon ,Dennie T Frederick ,Mehlika Hazar-Rethinam ,Brandon A Nadres ,Emily E Van Seventer ,Sachet A Shukla ,Keren Yizhak ,John P Ray ,Daniel Rosebrock ,Dimitri Livitz ,Viktor Adalsteinsson ,Gad Getz ,Lyn M Duncan ,Bo Li ,Ryan B Corcoran ,Donald P Lawrence ,Anat Stemmer-Rachamimov ,Genevieve M Boland ,Dan A Landau ,Keith T Flaherty ,Ryan J Sullivan ,Nir Hacohen